Bengalureans take a shine to anti-obesity drugs
Weight loss injectables like Ozempic have gained popularity in Bengaluru, with patients sourcing them from abroad. The ...
Tax Guru2d
Understanding Concept of Tax Deducted at Source (TDS) in India
Tax Deducted at Source (TDS) is a scheme launched by the Government of India for deduction of tax at the very source of income. It ensures each payment made will carry some portion of taxes being ...
Eli Lilly snaps six days of losses
Eli Lilly (LLY) shares snapped six straight days of losses as the stock closed 1.39% higher, at $812.76 on Friday. The ...
Donald Trump’s $1.4 trillion tariff threats scramble business plans, US companies form task-forces to tackle impact
Companies in the US, including Novo Nordisk, Boeing and Shein, are forming task forces to address the impact of Donald ...
FMIBlog4d
Global Acute Migraine Treatment Market Poised to Reach USD 4,194.1 Million by 2034 Amid Growing Awareness and Diagnosis | FMI
The global market for acute migraine treatment is on a steady growth trajectory, with sales expected to rise from USD 2,700.7 million in 2024 to USD 4,194.1 million by 2034, reflecting a CAGR of 4.5% ...
Diabetes drug price war heats up, making treatment more affordable
Homegrown pharmaceutical companies launching significantly cheaper generic versions of empagliflozin—a widely prescribed SGLT2 inhibitor for type-2 diabetes ...
Roche shares pop 4% on $5.3 billion obesity drug deal with Zealand Pharma
Swiss pharmaceutical giant Roche said Wednesday that it had struck a deal worth up to $5.3 billion to develop Zealand ...
News-Medical.Net5d
Tirzepatide helps people without diabetes lose 13% body weight in real-world study
A real-world study of over 4,000 US patients without type 2 diabetes found that those who persisted with Tirzepatide for at ...